CEOCFO Magazine Interview with Charles Dunlop 

FOR IMMEDIATE RELEASE

Ambry Genetics
15 Argonaut
Aliso Viejo, CA 92656

An Innovative Service Laboratory with Clinical Diagnostic and Genomic Services Divisons, Ambry Genetics Serves the Genetics Industry through Friendly, Knowledgeable Client Services and High Quality R&D in a Cutting-Edge Environment

Interview conducted by:
Lynn Fosse, Senior Editor
 

CEOCFO: Mr. Dunlop, would you tell us the vision when you founded Ambry Genetics and where are you today
Mr. Dunlop: Ambry Genetics is really an innovative company with a unique culture. We started Ambry when the stock market was really high and going the tech bubble. It was really the Glass-Steagall Act bubble. I still remember my father's words, "You may not be ready, but the money is inexpensive now. If you are ever going to start a company, now is the moment." I really thought about it and said, "I am on it." What really contributes to Ambry's unique culture is that it was truly funded by friends and family. In the beginning we only raised five hundred dollars to start the company and all of its operations. To this day everyone thinks that it is kind of crazy but there were no venture capital or institutional investors.

CEOCFO: What is the concept at Ambry Genetics?
Mr. Dunlop: Ambry is an innovative service laboratory with clinical diagnostic and genomic (research) services divisions. I started the company 13 years ago with a thought that we are going to do diagnose and focus on CF and neonatal markets. Several years later, it turned into me trying to keep the innovative spirit alive in different divisions and spokes that have grown from that basic idea. The growth i'm referring to is Ambry being first to introduce next-generation sequencing (NGS) technologies and whole-exome sequencing to the clinical diagnostic space. Today, Ambry us known as the leaders in NGS and we take pride in that. I started the company thinking that I am going to have this cool innovative company; it is going to be fun. It's true. Ambry's general mission is that we use the highest genetic technologies in the worl and apply them to medical problems that are appropriate. The ultimate goal is to find the answer.


Read Full Article Here


About Ambry Genetics ®

Ambry Genetics is both College of American Pathologists (CAP)-accredited and Clinical Laboratory Improvement Amendments (CLIA)-certified. Ambry leads in clinical genetic diagnostics and genetics software solutions, combining both to offer the most comprehensive testing menu in the industry. Ambry has established a reputation for sharing data while safeguarding patient privacy, unparalleled service, and responsibly applying new technologies to the clinical molecular diagnostics market. For more information about Ambry Genetics, visit ambrygen.com.

Press Contact:
Aaron Schmidt
Sr Manager, Communications
aschmidt@ambrygen.com
949 457 4679

Search Results

Start your search...